Steatotic liver disease subtypes exhibit distinct risk patterns of tachyarrhythmias and bradyarrhythmias
Steatotic liver disease subtypes exhibit distinct risk patterns of tachyarrhythmias and bradyarrhythmias
Background and aims: steatotic liver disease (SLD) is independently associated with cardiovascular disease; however, data on cardiac arrhythmias across individual SLD subtypes remain scarce. This study aimed to investigate associations between distinct SLD subtypes and arrhythmia risk.
Methods: using prospective UK Biobank data, participants were classified into four groups: no-SLD, metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol–associated steatotic liver disease (MetALD), and alcohol–associated liver disease (ALD). The primary outcome was incident overall arrhythmias, and secondary outcomes were specific arrhythmia subtypes. Multivariable Cox proportional hazards models assessed associations, and exploratory analyses evaluated subtype‑specific risk patterns.
Results: among 428,609 participants followed for a median of 14.23 years (IQR: 12.64–15.30), the cumulative incidence of arrhythmias increased progressively from no-SLD to MASLD, MetALD, and ALD (8.22%, 13.60%, 14.15%, and 16.43%, respectively). All SLD subtypes were independently associated with a higher risk of overall arrhythmias (MASLD: aHR = 1.39, 95% CI 1.36–1.42; MetALD: aHR = 1.43, 95% CI 1.38–1.48; ALD: aHR = 1.65, 95% CI 1.57–1.74; all P < 0.001). Atrial fibrillation and flutter (AF/AFL) accounted for 85.39% of tachyarrhythmias, and risk increased stepwise across the MASLD–MetALD–ALD spectrum. In contrast, bradyarrhythmias showed a distinct risk hierarchy, with MetALD conferring the highest risk (aHR = 1.44, 95% CI 1.32–1.56; P < 0.001), followed by MASLD (aHR = 1.39, 95% CI 1.32–1.47; P < 0.001) and ALD (aHR = 1.38, 95% CI 1.21–1.58; P < 0.001). Exploratory analyses suggested that alcohol‑related subtypes were more strongly associated with tachyarrhythmias than with bradyarrhythmias.
Conclusion: SLD subtypes were independently associated with a higher risk of incident arrhythmias, and the risk of AF/AFL increased stepwise across the MASLD–MetALD–ALD spectrum. Bradyarrhythmia risk was predominantly observed in metabolically related SLD subtypes. These findings suggest that SLD subtype classification is a relevant consideration for future risk stratification research, although its clinical applicability warrants further investigation.
Lin, Ya
c10fe8b1-89f7-4e77-a973-9c9e86725c11
Chen, Qin-Fen
c923bf6e-f46a-4a3b-94a2-b6a54b23c0e5
Xia, Tianyi
be721a58-5e19-42b6-a2a0-6c54f106aa66
Byrne, Chris
1370b997-cead-4229-83a7-53301ed2a43c
Lin, Ya
c10fe8b1-89f7-4e77-a973-9c9e86725c11
Chen, Qin-Fen
c923bf6e-f46a-4a3b-94a2-b6a54b23c0e5
Xia, Tianyi
be721a58-5e19-42b6-a2a0-6c54f106aa66
Byrne, Chris
1370b997-cead-4229-83a7-53301ed2a43c
Lin, Ya, Chen, Qin-Fen and Xia, Tianyi
,
et al. and CHAIN Consortium
(2026)
Steatotic liver disease subtypes exhibit distinct risk patterns of tachyarrhythmias and bradyarrhythmias.
Cardiovascular Diabetology.
(doi:10.1186/s12933-026-03305-x).
Abstract
Background and aims: steatotic liver disease (SLD) is independently associated with cardiovascular disease; however, data on cardiac arrhythmias across individual SLD subtypes remain scarce. This study aimed to investigate associations between distinct SLD subtypes and arrhythmia risk.
Methods: using prospective UK Biobank data, participants were classified into four groups: no-SLD, metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol–associated steatotic liver disease (MetALD), and alcohol–associated liver disease (ALD). The primary outcome was incident overall arrhythmias, and secondary outcomes were specific arrhythmia subtypes. Multivariable Cox proportional hazards models assessed associations, and exploratory analyses evaluated subtype‑specific risk patterns.
Results: among 428,609 participants followed for a median of 14.23 years (IQR: 12.64–15.30), the cumulative incidence of arrhythmias increased progressively from no-SLD to MASLD, MetALD, and ALD (8.22%, 13.60%, 14.15%, and 16.43%, respectively). All SLD subtypes were independently associated with a higher risk of overall arrhythmias (MASLD: aHR = 1.39, 95% CI 1.36–1.42; MetALD: aHR = 1.43, 95% CI 1.38–1.48; ALD: aHR = 1.65, 95% CI 1.57–1.74; all P < 0.001). Atrial fibrillation and flutter (AF/AFL) accounted for 85.39% of tachyarrhythmias, and risk increased stepwise across the MASLD–MetALD–ALD spectrum. In contrast, bradyarrhythmias showed a distinct risk hierarchy, with MetALD conferring the highest risk (aHR = 1.44, 95% CI 1.32–1.56; P < 0.001), followed by MASLD (aHR = 1.39, 95% CI 1.32–1.47; P < 0.001) and ALD (aHR = 1.38, 95% CI 1.21–1.58; P < 0.001). Exploratory analyses suggested that alcohol‑related subtypes were more strongly associated with tachyarrhythmias than with bradyarrhythmias.
Conclusion: SLD subtypes were independently associated with a higher risk of incident arrhythmias, and the risk of AF/AFL increased stepwise across the MASLD–MetALD–ALD spectrum. Bradyarrhythmia risk was predominantly observed in metabolically related SLD subtypes. These findings suggest that SLD subtype classification is a relevant consideration for future risk stratification research, although its clinical applicability warrants further investigation.
Text
Reviewed_manuscript_with_highlighted20260715
- Accepted Manuscript
Text
Supplementary Tables20260703
- Accepted Manuscript
Text
Tables20260703
- Accepted Manuscript
Text
Figures20260709
- Accepted Manuscript
Text
Supplementary Figures20260707
- Accepted Manuscript
Show all 5 downloads.
More information
Accepted/In Press date: 16 July 2026
e-pub ahead of print date: 22 August 2026
Identifiers
Local EPrints ID: 515077
URI: https://eprints.soton.ac.uk/id/eprint/515077
ISSN: 1475-2840
PURE UUID: 93987f86-d777-453a-82a1-1cee8a85f8da
Catalogue record
Date deposited: 05 Oct 2026 16:53
Last modified: 10 Oct 2026 01:39
Export record
Altmetrics
Contributors
Author:
Ya Lin
Author:
Qin-Fen Chen
Author:
Tianyi Xia
Corporate Author: et al.
Corporate Author: CHAIN Consortium
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics